A 15 yr old boy suffering from epiliepsy is on treatment with a combination of Phenytoin and Valproate. Both the drugs levels are in the level of therapeutic range. Which of the following is not an adverse effect of Valproate?

**Core Concept**
Valproate is an antiepileptic medication that can cause a range of adverse effects due to its mechanism of action as a sodium channel blocker and GABA receptor agonist. It is often used in combination with other antiepileptic drugs like Phenytoin to manage seizures.

**Why the Correct Answer is Right**
Valproate is known to cause several adverse effects, including weight gain, teratogenicity (birth defects), and liver enzyme elevations. However, it is not typically associated with causing a decrease in platelet count, which is a common side effect of Phenytoin. Valproate can actually increase the risk of bleeding due to its effect on platelet aggregation.

**Why Each Wrong Option is Incorrect**
* **Option A:** Weight gain is a well-documented side effect of Valproate, making it a correct statement.
* **Option B:** Liver enzyme elevations are a known risk of Valproate therapy, especially during the initial stages of treatment.
* **Option C:** Teratogenicity is a significant concern with Valproate use in pregnancy, highlighting the importance of effective contraception in women of childbearing age.

**Clinical Pearl / High-Yield Fact**
Valproate is a teratogen that can cause neural tube defects (NTDs) and other congenital anomalies, and its use in pregnancy should be carefully weighed against the benefits of seizure control.

**Correct Answer:** D. Decrease in platelet count is not a common adverse effect of Valproate.

✓ Correct Answer: D. Lymphadenopathy